Amlos H

An evidence-based hypertension combination providing ARB-mediated vasodilation (losartan) with thiazide diuresis (HCTZ). (Messerli FH, 2000) The losartan component counters HCTZ-induced hypokalemia while preserving uric acid excretion. (Burnier M, 2001) First-choice therapy for hypertensive patients with metabolic syndrome. (Kintscher U, 2007)

Indication

• Stage 1-2 hypertension
• Hypertensive nephropathy
• LVH regression
• Diuretic-potentiated therapy

Side Effects

• Hypotension
• Hyperuricemia
• Muscle cramps
• Dizziness